Re-evaluation of time to progression of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients clinically resistant to ganciclovir.
Mueller
A J
AJ
Jacobson
M A
MA
Hurwitz
S
S
Chuang
E L
EL
Friedberg
D N
DN
Haidt
S J
SJ
Heinemann
M H
MH
Jabs
D A
DA
Kaplan
H J
HJ
Freeman
W R
WR
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy*; D018450:Disease Progression; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D016879:Salvage Therapy
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D017245:Foscarnet; D015774:Ganciclovir